Han et al. indicated that in osteosarcoma, M2-type TAMs enhance the function of TIM-3(+)PD-1(+) T cells, thereby intensifying T cell immunosuppression within the TME (Han et al., 2016). This evidence concerns the gene HAVCR2 and osteosarcoma.